CompanyLLY

Eli Lilly

Eli Lilly is tracked across RERIGHT’s news graph. Explore its connections and the latest headlines below.

Latest on Eli Lilly

STAT+: Eli Lilly targets booming black market for retatrutide
Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide
STAT+: Eli Lilly to allow more patients to apply for special access to unapproved obesity drug
STAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit
Pharma heavyweights Novo Nordisk and Eli Lilly clash over anti-obesity drug ads
STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
13F: S&A Financial Services holds Eli Lilly ($390,593)
13F: First National Bank Of Mount Dora Trust Investment Services holds Eli Lilly ($12M)
13F: Goodwin Investment Advisory holds Eli Lilly ($298,658)
13F: Prosperitas Financial Llc holds Eli Lilly ($6M)
13F: Sustainable Insight Capital Management Llc holds Eli Lilly ($12M)
13F: Concorde Asset Management Llc holds Eli Lilly ($782,576)